SCHEMBL1199262

SCHEMBL1199262

O=Cc1ccccc1OC(=O)Cc1cccc2ccccc12

nearest known ligand 0.68

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 4/20 0.68
TDP1 Q9NUW8 2/20 0.57
SIRT5 Q9NXA8 1/20 0.54
KDM4E B2RXH2 2/20 0.49
CYP1A2 P05177 1/20 0.49
CYP3A4 P08684 1/20 0.49
CYP2C19 P33261 1/20 0.49
AKR1C3 P42330 1/20 0.48
AKR1C2 P52895 1/20 0.48
ATM Q13315 1/20 0.45
MEN1 O00255 2/20 0.44
KMT2A Q03164 2/20 0.44
PKM P14618 2/20 0.44
LMNA P02545 1/20 0.44
PTGDR2 Q9Y5Y4 1/20 0.44
ALDH1A1 P00352 4/20 0.44
HTT P42858 2/20 0.44
HPGD P15428 1/20 0.44
SMN1; SMN2 Q16637 1/20 0.44
PGR P06401 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5888866 0.90 L3MBTL1 (0.78) L3MBTL1TDP1SIRT5KDM4ECYP1A2
SCHEMBL3155070 0.81 L3MBTL1 (0.70) L3MBTL1TDP1SIRT5KDM4ECYP1A2
SCHEMBL28102502 0.80 L3MBTL1 (0.64) L3MBTL1TDP1SIRT5KDM4ECYP1A2
SCHEMBL13222634 0.79 L3MBTL1 (0.67) L3MBTL1TDP1SIRT5KDM4ECYP1A2
SCHEMBL28818018 0.78 L3MBTL1 (0.65) L3MBTL1TDP1SIRT5KDM4ECYP1A2
SCHEMBL5880095 0.78 KMT2A (0.60) L3MBTL1TDP1KDM4ECYP1A2CYP3A4
SCHEMBL3052007 0.77 L3MBTL1 (0.78) L3MBTL1TDP1SIRT5KDM4ECYP1A2
SCHEMBL28171279 0.77 TDP1 (0.59) L3MBTL1TDP1SIRT5KDM4ECYP1A2
SCHEMBL590845 0.76 TDP1 (0.67) L3MBTL1TDP1SIRT5KDM4ECYP1A2
SCHEMBL1201192 0.75 PTGDR2 (0.56) L3MBTL1TDP1ATMKMT2ALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2154123-B1 METHOD FOR PRODUCING BENZALDEHYDE COMPOUND SUMITOMO CHEMICAL CO (JP) 2013-10-23 EP disclosed
US-8309753-B2 Method for producing optically active cyanohydrin compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-11-13 US disclosed
US-20110034718-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE CYANOHYDRIN COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-02-10 US disclosed
EP-2264005-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE CYANOHYDRIN COMPOUND Sumitomo Chemical Company, Limited (JP) 2010-12-22 EP disclosed
US-7851659-B2 Method for producing benzaldehyde compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-12-14 US disclosed
US-20100234645-A1 METHOD FOR PRODUCING BENZALDEHYDE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-16 US disclosed
EP-2154123-A1 METHOD FOR PRODUCING BENZALDEHYDE COMPOUND Sumitomo Chemical Company, Limited (JP) 2010-02-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234645-A1 METHOD FOR PRODUCING BENZALDEHYDE COMPOUND NQO1, NQO2, NDUFC2 L3MBTL1 2864/4885TDP1 2422/4885SIRT5 695/4885
US-20110034718-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE CYANOHYDRIN COMPOUND CBR3, ACSL3, CCNL2 L3MBTL1 430/4885TDP1 4826/4885SIRT5 211/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.